• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射布美他尼在充血性心力衰竭中产生的血流动力学变化

[Hemodynamic changes produced by intravenous bumetanide in congestive heart failure].

作者信息

Ziacchi V, Rossi A, Lomanto B

出版信息

G Ital Cardiol. 1981;11(1):104-9.

PMID:7239091
Abstract

The hemodynamic variations brought about by the single intravenous infection of 0,5 mg bumetanide have been studied in 7 patients with chronic ischemic heart disease and in 3 patients with non-obstructive hypertrophic cardiomyopathy, all of them in congestive heart failure. The technique employed has been the right heart micro-catheterization. The following parameters have been studied: heart rate, systemic systolic and diastolic pressures, mean pulmonary pressure, end-diastolic pulmonary pressure, total systemic and pulmonary resistances, cardiac index, systolic index, left ventricular systolic work index, timed diuresis, pH, pO2, pCO2, for a four-hours period of observation. Results have been statistically analyzed with the sign test. Bumetanide has brought about a significative reduction of the right pressures and of resistances both in pulmonary and systemic circulations, without any effect on ventricular function indexes. These effects have appeared very early, already within the first 5 m', have remained constant till the end of the experiment and have always preceded the diuretic response. These results allow the view that bumetanide has a double action, initially vascular, then diuretic.

摘要

对7例慢性缺血性心脏病患者和3例非梗阻性肥厚型心肌病患者(均为充血性心力衰竭)进行了研究,观察单次静脉注射0.5毫克布美他尼所引起的血流动力学变化。采用的技术是右心微导管插入术。观察了以下参数:心率、体循环收缩压和舒张压、平均肺动脉压、舒张末期肺动脉压、总体循环和肺循环阻力、心脏指数、收缩指数、左心室收缩作功指数、定时尿量、pH值、氧分压、二氧化碳分压,观察期为4小时。结果采用符号检验进行统计学分析。布美他尼使肺循环和体循环中的右心压力和阻力显著降低,而对心室功能指标无任何影响。这些作用出现得非常早,在最初5分钟内就已出现,直至实验结束一直保持不变,并且总是先于利尿反应出现。这些结果表明布美他尼具有双重作用,最初是血管作用,然后是利尿作用。

相似文献

1
[Hemodynamic changes produced by intravenous bumetanide in congestive heart failure].静脉注射布美他尼在充血性心力衰竭中产生的血流动力学变化
G Ital Cardiol. 1981;11(1):104-9.
2
The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.双重内皮素受体拮抗剂替唑生坦可迅速改善晚期心力衰竭患者的血流动力学参数。
Am Heart J. 2001 Aug;142(2):340-9. doi: 10.1067/mhj.2001.116760.
3
Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.A1腺苷受体拮抗剂SLV320对心力衰竭患者的心肾影响
Circ Heart Fail. 2009 Nov;2(6):523-31. doi: 10.1161/CIRCHEARTFAILURE.108.798389. Epub 2009 Sep 24.
4
[Hemodynamic effects of hydralazine in the cardiac insufficiency of non-obstructive myocardiopathy].
Arch Mal Coeur Vaiss. 1979 Mar;72(3):276-83.
5
[Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure].[重组人脑利钠肽对心力衰竭犬心脏血流动力学及肾功能的影响]
Yao Xue Xue Bao. 2002 Oct;37(10):758-62.
6
[Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].[多巴酚丁胺诱导的严重心力衰竭患者血流动力学参数及心房利钠肽循环水平的急性变化]
G Ital Cardiol. 1996 Aug;26(8):863-74.
7
A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states.布美他尼与呋塞米治疗充血性心力衰竭及其他水肿状态的比较随机双盲临床试验。
Int J Clin Pharmacol Ther Toxicol. 1984 Sep;22(9):473-8.
8
Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure.充血性心力衰竭患者停用利尿剂期间的连续血流动力学监测。
Eur Heart J. 2002 Jan;23(1):59-69. doi: 10.1053/euhj.2001.2690.
9
[Hemodynamic effects of one administration of l-dopa in patients with left ventricular heart failure (introductory remarks)].
Kardiol Pol. 1993 May;38(5):335-9.
10
Early and medium term results of tailored therapy for heart failure.心力衰竭个体化治疗的早期和中期结果
Rev Port Cardiol. 2001 Mar;20(3):261-82.

引用本文的文献

1
Central hemodynamic effects of diuretic therapy in chronic heart failure.利尿剂治疗对慢性心力衰竭的中心血流动力学影响
Cardiovasc Drugs Ther. 1993 Jan;7 Suppl 1:45-53. doi: 10.1007/BF00877957.
2
Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.布美他尼。对其药效学、药代动力学特性及治疗用途的综述。
Drugs. 1984 Nov;28(5):426-64. doi: 10.2165/00003495-198428050-00003.
3
Comparison of the acute vascular effects of frusemide and bumetanide.速尿和布美他尼急性血管效应的比较。
Br J Clin Pharmacol. 1986 Apr;21(4):359-64. doi: 10.1111/j.1365-2125.1986.tb05207.x.
4
Immediate effects of bumetanide on systemic haemodynamics and left ventricular volume in acute and chronic heart failure.布美他尼对急慢性心力衰竭患者全身血流动力学及左心室容量的即时影响。
Br J Clin Pharmacol. 1987 Jul;24(1):21-32. doi: 10.1111/j.1365-2125.1987.tb03131.x.
5
Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. Ireland, 6-8 July, 1988. Abstracts.英国药理学会临床药理学分会会议记录。爱尔兰,1988年7月6日至8日。摘要。
Br J Clin Pharmacol. 1988 Nov;26(5):615P-678P.